November 15, 2021 10:44 AM Eastern Daylight Time
BUSINESS WIRE
Riassunto: BESREMi® (ropeginterferone alfa-2b) ottiene l'approvazione della FDA statunitense
Dr. Rudolf Widmann Member of the Governing Board AOP Orphan International Copyright: Unkart
Tweet
View Full Size
Download
Full Size
JPEG
,
2400
x
3600
,
957.2 KB
Small
JPEG
,
320
x
480
,
49.5 KB
Preview
JPEG
,
96
x
144
,
37.1 KB
Thumbnail
JPEG
,
48
x
72
,
35.6 KB
Smart Multimedia Gallery
Dr. Rudolf Widmann Member of the Governing Board AOP Orphan International Copyright: Unkart
View and Share Logo
Download Full Size
Download Small
Share
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
Email
All News
|
News with Multimedia
>
Press Release: Riassunto: BESREMi® (ropeginterferone alfa-2b) ...